Cancer is a devastating disease for families across the globe. According to the U.S. National Cancer Institute, there were 14 million new cancers and 8.2 million deaths related to cancer worldwide in 2012 alone. Researchers continue to learn about the biology of cancer and how it affects the body. They are developing innovative new treatments with the hopes of extending life and one day finding cures.
Cancer Immunotherapies: From Magic Bullets to Super T Cells
Posted on: July 11, 2018
Cancer Immunotherapies: From Magic Bullets to Super T Cells - Immunotherapy encompasses multiple approaches, including harnessing or enhancing immune cells, hormones, and other weapons of the immune system to destroy tumor cells, as well as releasing the brakes on the immune response that tumors trigger. This new article takes the reader on a journey from the origins of using toxins to prime the body’s immune system to attack tumors through today’s advances that genetically alter immune cells to fight cancer. Download the PDF or listen to the podcast below.
Liquid Biopsies: A New Way to Diagnose, Understand & Track Cancer
Posted on: November 02, 2017
Liquid Biopsies: A New Way to Diagnose, Understand & Track Cancer - Liquid Biopsy enables clinicians to test DNA shed by dying tumors in human fluids to help track cancer progression. By using this innovative technology, physicians can also create highly individualized treatment plans for specific types of cancer. This process complements existing approaches that use surgery, radiation, and chemotherapy to save lives. Download the PDF or listen to the podcast below:
Nanomedicine: A Targeted Approach
Posted on: March 12, 2015
Nanomedicine: A Targeted Approach - Nanomedicine is beginning to change the way scientists and physicians diagnose and treat disease. Unlike conventional therapies, these tiny particles – 1,000 times smaller than the diameter of a human hair – can seek out diseased tissue and access hard to reach places in the body. This article will provide readers with an understanding of what nanoparticles are, how they specifically target diseased tissue, and how they diagnose and treat some of our most devastating diseases. Read more...
FASEB Releases Its Newest Publication in the Breakthroughs in Bioscience Series
Posted on: September 08, 2014
Individualized Medicine - Individualized medicine, also known as personalized medicine or genomic medicine, is an approach to medical practice that offers customizable diagnosis and treatment of disease based on one’s genetic make-up. Innovations in individualized medicine come from technological advances that make it feasible to decode a person’s genome. In this article, readers will learn how scientists exploring answers to basic questions about microbes, cancer, the immune system, and other biological processes fostered the current genetic revolution in medicine that is helping physicians find the right treatment for the right patient at the right time. Read more...
Epigenetics: Looking Beyond Our DNA
Posted on: April 30, 2014
Epigenetics: Looking Beyond Our DNA - Our physical appearance and susceptibility to disease were once thought to be hard-wired within our DNA, but now scientists are starting to decipher how biological and environmental factors influence health disease. Epigenetics is a rapidly advancing area of investigation in which changes in gene expression as a result of DNA modifications rather than from changes in the underlying DNA sequence are studied. With support from the National Institutes of Health and other federal agencies, the study of epigenetics has led to the development of therapies for cancer and to a better understanding of disease susceptibility. Read more...
FASEB Releases New Breakthroughs in Bioscience Article Titled Conquering Cancer With Drugs From Nature's Medicine Cabinet
Posted on: April 23, 2013
Conquering Cancer with Drugs from Nature's Medicine Cabinet - Despite a four-decade “war on cancer,” this year, 1.5 million Americans will be diagnosed with a form of this broad group of diseases, and a half million will die as a result. Beginning in the late 1930’s - early 1940’s, researchers were inspired by the success in treating infectious diseases with chemicals isolated from microorganisms and other natural products, such as penicillin from a fungus. Could chemicals battle cancer too? Download the PDF or listen to the podcast below:
FASEB Releases New Breakthroughs In Bioscience Article Entitled "Spying On Cancer With PET Scans"
Posted on: July 19, 2011
Spying on Cancer with PET Scans - The ability to peer inside the body non-invasively has revolutionized modern medicine. With positron emission tomography (PET), physicians can not only look at the body’s internal structures, but can see the metabolic signs of disease. Download the PDF or listen to the podcast below:
How Biomedical Research Provides Fertility Hope to Cancer Survivors
Posted on: March 12, 2011
How Biomedical Research Provides Fertility Hope to Cancer Survivors - The process of reproduction has fascinated humans since ancient times. Hippocrates and Aristotle offered theories on conception and fertility, but it was not until the late 17th century that a Dutch scientist named Niels Stensen, who was studying the reproductive organs of animals, suggested that human ovaries might contain egg cells, or oocytes. Over a century later, this was definitively confirmed by one of the founding fathers of embryology, Carl Ernst von Baer. Read more...
FASEB Releases New Breakthroughs in Bioscience Article Entitled "Life's Blood: Angiogenesis in Health and Disease"
Posted on: July 19, 2010
Life's Blood: Angiogenesis in Health and Disease - Angiogenesis, or the formation of new blood vessels, plays a critical role in a number of diseases and conditions, including cancer, diabetic retinopathy, and wound healing. Read more..
FASEB Breakthroughs In Bioscience Describes Development Of Monoclonal Antibody Therapies
Posted on: January 21, 2010
Magic Bullets and Monoclonals: An Antibody Tale - Nearly a century of basic discovery in immunology, cell biology, and cancer biology contributed to today's remarkable monoclonal antibody therapies, which are produced through human-mouse cell hybrids. Read more...